Andrew HopkinsonFounder

United Kingdom - Nottinghamshire, England

Chief Scientific Officer, NuVision Biotherapies; and Honorary Principal Research Fellow (Honorary Ass Professor) Ocular Surface Regenerative Medicine, Academic Ophthalmology, University of Nottingham.

- Performance driven early stage health technology CEO and CSO with a track record in conceptualising, developing, translating and commercialising novel healthcare-driven innovation.

- Translational scientist and entrepreneur with a strong molecular biology background focusing on innovative regenerative technologies.

- A highly resourceful and innovative results-orientated enterprising academic, with extensive bio-entrepreneurial skills operating in an interdisciplinary field, within basic and applied research environments.

- Effective design and execution research plans through to commercialisation in a competitive market

- Experienced in intellectual property discovery, development, protection and potential commercialisation.

- Forged and expedited high impact international clinical, SME & biotech tissue engineering collaborations .

- Experience in fund-raising and collaborative ventures with industry and academia.

- Project management skills with effective control of budget, milestones and deliverables.